Antidepressant “Black Box” Decision Imminent, FDA Tells Congress
FDA will reach an internal decision on whether to request a "black box" warning on pediatric suicidality for all antidepressant labeling as early as the week of Sept. 27
FDA will reach an internal decision on whether to request a "black box" warning on pediatric suicidality for all antidepressant labeling as early as the week of Sept. 27